Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H14N4O3S |
Molecular Weight | 294.33 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC(C)=N1
InChI
InChIKey=QKLSCPPJEVXONT-UHFFFAOYSA-N
InChI=1S/C12H14N4O3S/c1-8-14-11(7-12(15-8)19-2)16-20(17,18)10-5-3-9(13)4-6-10/h3-7H,13H2,1-2H3,(H,14,15,16)
DescriptionSources: http://drugs-about.com/ing/sulfametomidine.htmlCurator's Comment: description was created based on several sources, including
http://datagovtw.com/fda.php?id=%E5%85%A7%E8%A1%9B%E8%97%A5%E8%A3%BD%E5%AD%97%E7%AC%AC016294%E8%99%9F
Sources: http://drugs-about.com/ing/sulfametomidine.html
Curator's Comment: description was created based on several sources, including
http://datagovtw.com/fda.php?id=%E5%85%A7%E8%A1%9B%E8%97%A5%E8%A3%BD%E5%AD%97%E7%AC%AC016294%E8%99%9F
Sulfametomidine (or sulfamethomidine) is a sulfonamide antibacterial with a broad spectrum of activity; it’s an inhibitor of dihydrofolate reductase.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/13895996
Curator's Comment: http://datagovtw.com/fda.php?id=%E5%85%A7%E8%A1%9B%E8%97%A5%E8%A3%BD%E5%AD%97%E7%AC%AC016294%E8%99%9F
initially 2 mg. subsequently 24 hour intervals in an average total dose of 6.3 mg.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
J01ED03
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1126
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
3772-76-7
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
940ZL3AHKB
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
SUB10713MIG
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
C72851
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
SULFAMETOMIDINE
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
223-219-5
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
DTXSID0023616
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
m10319
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000083271
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
19596
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL485940
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
DB13485
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY | |||
|
2513
Created by
admin on Sat Dec 16 16:13:51 GMT 2023 , Edited by admin on Sat Dec 16 16:13:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY